Xenon Pharmaceuticals XENE Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's operating lease ROU assets?
- Xenon Pharmaceuticals (XENE) reported operating lease ROU assets of $6.29M in Q1 2026.
- How has Xenon Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Xenon Pharmaceuticals's operating lease ROU assets decreased by 17.4% year-over-year, from $7.62M to $6.29M.
- What is the long-term trend for Xenon Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's operating lease ROU assets has grown at a 14.8% compound annual growth rate (CAGR), from $3.33M to $6.63M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.